1-6 of 6
Virginia Pate
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Antihyperglycemic Medication Use Among U.S. Adults With Hemodialysis-Dependent Kidney Disease and Comorbid Diabetes

Klara R. Klein, Virginia Pate, Magdalene M. Assimon, Til Stürmer, John B. Buse, Jennifer E. Flythe
Journal: Diabetes Care
Diabetes Care 2022;45(9):126–128
https://doi.org/10.2337/dc22-0659
Published: 21 July 2022
View article titled, Antihyperglycemic Medication Use Among U.S. Adults With Hemodialysis-Dependent Kidney Disease and Comorbid Diabetes
Open the PDF for Antihyperglycemic Medication Use Among U.S. Adults With Hemodialysis-Dependent Kidney Disease and Comorbid Diabetes in another window
Journal Articles

Decreased Antihyperglycemic Drug Use Driven by High Out-of-Pocket Costs Despite Medicare Coverage Gap Closure

Mugdha Gokhale, Stacie B. Dusetzina, Virginia Pate, Danielle S. Chun, John B. Buse, Til Stürmer, Emily W. Gower
Journal: Diabetes Care
Diabetes Care 2020;43(9):2121–2127
https://doi.org/10.2337/dc19-1880
Published: 08 July 2020
View article titled, Decreased Antihyperglycemic Drug Use Driven by High Out-of-Pocket Costs Despite Medicare Coverage Gap Closure
Open the PDF for Decreased Antihyperglycemic Drug Use Driven by High Out-of-Pocket Costs Despite Medicare Coverage Gap Closure in another window
Journal Articles

Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults

Tiansheng Wang, Jeff Y. Yang, John B. Buse, Virginia Pate, Huilin Tang, Edward L. Barnes, Robert S. Sandler, Til Stürmer
Journal: Diabetes Care
Diabetes Care 2019;42(11):2065–2074
https://doi.org/10.2337/dc19-0162
Published: 30 August 2019
View article titled, Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults
Open the PDF for Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults in another window
Includes: Supplementary data
Journal Articles

Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults

Tiansheng Wang, Jin-Liern Hong, Emily W. Gower, Virginia Pate, Seema Garg, John B. Buse, Til Stürmer
Journal: Diabetes Care
Diabetes Care 2018;41(9):1998–2009
https://doi.org/10.2337/dc17-2285
Published: 16 July 2018
View article titled, Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults
Open the PDF for Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults in another window
Includes: Supplementary data
Journal Articles

The Risk of Acute Pancreatitis After Initiation of Dipeptidyl Peptidase 4 Inhibitors: Testing a Hypothesis of Subgroup Differences in Older U.S. Adults

Jin-Liern Hong, John B. Buse, Michele Jonsson Funk, Virginia Pate, Til Stürmer
Journal: Diabetes Care
Diabetes Care 2018;41(6):1196–1203
https://doi.org/10.2337/dc17-2212
Published: 04 April 2018
View article titled, The Risk of Acute Pancreatitis After Initiation of Dipeptidyl Peptidase 4 Inhibitors: Testing a Hypothesis of Subgroup Differences in Older U.S. Adults
Open the PDF for The Risk of Acute Pancreatitis After Initiation of Dipeptidyl Peptidase 4 Inhibitors: Testing a Hypothesis of Subgroup Differences in Older U.S. Adults in another window
Includes: Supplementary data
Journal Articles

Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin

Til Stürmer, MD, M. Alison Marquis, MSTAT, Haibo Zhou, PHD, James B. Meigs, MD, Soo Lim, MD, Lawrence Blonde, MD, Eileen MacDonald, MD, Ray Wang, MS, Lisa M. LaVange, PHD, Virginia Pate, MS, John B. Buse, MD
Journal: Diabetes Care
Diabetes Care 2013;36(11):3517–3525
https://doi.org/10.2337/dc13-0263
Published: 15 October 2013
View article titled, Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin
Open the PDF for Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin in another window
Includes: Supplementary data